A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
Monitoring for signs of dehydrationincluding decreased urine output, dry mouth, and dizzinessis essential, particularly during dose escalation periods when gastrointestinal side effects are most pronounced
Why Peptide Sellers Are at Risk (Even Without a Ban) Heres the kicker: Compliance doesnt just depend on your product, it depends on your messaging
We are disclosing this in accordance with the Federal Trade Commission's 16 CFR, Part 255: "Guides Concerning the Use of Endorsements and Testimonials."
Furthermore, we provide integrated post-surgical scar care packagesincluding specialized silicone sheets and advanced laser therapiesto ensure your incisions heal smoothly and fade cleanly into your natural skin tones over time